Cooley advised Janux Therapeutics, and Wilson Sonsini Goodrich & Rosati advised the company on patent matters related to the transaction, while Latham & Watkins advised the...
Janux Therapeutics’ $350 Million Common Stock Offering
TeraWulf’s $500 Million Convertible Notes Offering
DLA Piper advised the initial purchasers on the offering. TeraWulf Inc. completed its offering of US$500 million aggregate principal amount of 2.75% Convertible Senior Notes due...
MicroStrategy Incorporated’s $21 Billion At-the-Market Equity Offering
Wilmer Cutler Pickering Hale advised MicroStrategy Incorporated, and Davis Polk advised the Agents on the offering. MicroStrategy Incorporated (MicroStrategy) (Nasdaq: MSTR) announced the company’s new at-the-market...
Bicara Therapeutics’ $315 Million IPO
Goodwin Procter advised Bicara Therapeutics on the offering, and Ropes & Gray advised the underwriters. Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company, announced the...
Zura Bio’s Warrant Exchange Offer and Consent Solicitation
DLA Piper advised Cantor Fitzgerald on the transaction. The transaction consisted in an offer to exchange certain outstanding warrants to purchase Class A ordinary shares of...
Rezolute’s $60 Million Common Stock Offering
Dorsey & Whitney advised Rezolute, while Paul Hastings advised Jefferies and Cantor as joint book-running managers in the offering. Rezolute, Inc. (Nasdaq: RZLT) completed its underwritten...
Biohaven’s $264.5 Million Follow-On Offering
Maples and Calder acted as British Virgin Island counsel to Biohaven Ltd., and Sullivan & Cromwell acted as US counsel, while Ropes & Gray represented the...
Humacyte’s $40 Million Public Offering
Covington & Burling represented Humacyte, while Paul Hastings advised TD Cowen, Cantor and BTIG in the offering. Humacyte, Inc. executed an underwritten public offering of 13,400,000 shares...
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Alector’s $75 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati represented Alector in the offering, and Davis Polk & Wardwell represented the sole book-running manager and underwriter, Cantor Fitzgerald & Co....
Newmark Group’s $600 Million Senior Notes Offering
Sidley Austin represented BofA Securities, Inc., Cantor Fitzgerald & Co., Goldman Sachs & Co. LLC, PNC Capital Markets LLC, Regions Securities LLC, and Wells Fargo Securities,...
Celldex Therapeutics’ $230.5 Million Common Stock Offering
Lowenstein Sandler advised Celldex Therapeutics, Inc. on the offering, and Wilmer Cutler Pickering Hale and Dorr advised the underwriters. Celldex Therapeutics, Inc. (Nasdaq: CLDX) (“Celldex”) announced the...